Association of cerebrospinal fluid anti-Sm antibodies with acute confusional state in systemic lupus erythematosus

Arthritis Research and Therapy

Volumn 16, Issue 1, 2014, Pages

  Hirohata, Shunsei ^a   Sakuma, Yuko ^a   Yanagida, Tamiko ^b   Yoshio, Taku ^c  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; MONOCLONAL ANTIBODY; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; Q ALBUMIN; RIBONUCLEOPROTEIN ANTIBODY; SM ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY; PROTEIN BINDING; SMALL NUCLEAR RIBONUCLEOPROTEIN;

ACUTE CONFUSIONAL STATE; ADULT; ANTIBODY BLOOD LEVEL; ANTIGEN BINDING; ARTICLE; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID LEVEL; CONFUSION; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; NERVE CELL; NEUROBLASTOMA CELL LINE; NEUROPATHOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; ACUTE DISEASE; ANIMAL; BLOOD; BRAIN VASCULITIS; CEREBROSPINAL FLUID; IMMUNOLOGY; METABOLISM; MIDDLE AGED; TUMOR CELL LINE;

ACUTE DISEASE; ADULT; ANIMALS; AUTOANTIBODIES; BLOOD-BRAIN BARRIER; CELL LINE, TUMOR; CONFUSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MALE; MIDDLE AGED; PROTEIN BINDING; SNRNP CORE PROTEINS;

EID: 84988896856     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/s13075-014-0450-z     Document Type: Article

References (29)

1. Gibson T, Myers AR: Nervous system involvement in systemic lupus erythematosus. Ann Rheum Dis 1975, 35:398-406.
2. Harris EN, Hughes GR: Cerebral disease in systemic lupus erythematosus. Springer Semin Immunopathol 1985, 8:251-266.
3. Bluestein HG, Williams GW, Steinberg AD: Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus. Am J Med 1981, 70:240-246.
4. Isshi K, Hirohata S: Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus. Arthritis Rheum 1998, 41:1819-1827.
5. Furukawa H, Singh SK, Mancusso R, Gouaux E: Subunit arrangement and function in NMDA receptors. Nature 2005, 438:185-192.
6. DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B: A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001, 7:1189-1193.
7. Kowal C, DeGiorgio LA, Nakaoka T, Hetherington H, Huerta PT, Diamond B, Volpe BT: Cognition and immunity; antibody impairs memory. Immunity 2004, 21:179-188.
8. Arinuma Y, Yanagida T, Hirohata S: Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 2008, 58:1130-1135.
9. Winfield JB, Brunner CM, Koffler D: Serologic studies in patients with systemic lupus erythematosus and central nervous system dysfunction. Arthritis Rheum 1978, 21:289-294.
10. Yasuma M, Takasaki Y, Matsumoto K, Kodama A, Hashimoto H, Hirose S: Clinical significance of IgG anti-Sm antibodies in patients with systemic lupus erythematosus. J Rheumatol 1990, 17:469-475.
11. Hirohata S, Kosaka M: Association of anti-Sm antibodies with organic brain syndrome secondary to systemic lupus erythematosus. Lancet 1994, 343:796.
12. Sato T, Fujii T, Yokoyama T, Fujita Y, Imura Y, Yukawa N, Kawabata D, Nojima T, Ohmura K, Usui T, Mimori T: Anti-U1 RNP antibodies in cerebrospinal fluid are associated with central neuropsychiatric manifestations in systemic lupus erythematosus and mixed connective tissue disease. Arthritis Rheum 2010, 62:3730-3740.
13. Reuter R, Lührmann R: Immunization of mice with purified U1 small nuclear ribonucleoprotein (RNP) induces a pattern of antibody specificities characteristic of the anti-Sm and anti-RNP autoimmune response of patients with lupus erythematosus, as measured by monoclonal antibodies. Proc Natl Acad Sci U S A 1986, 83:8689-8693.
14. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277.
15. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature: The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999, 42:599-608.
16. Tibbling G, Link H, Ohman S: Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest 1977, 37:385-390.
17. Hirohata S, Nakanishi K: Antiribosomal P protein antibody in human systemic lupus erythematosus reacts specifically with activated T cells. Lupus 2001, 10:612-621.
18. Winfield JB, Shaw M, Silverman LM, Eisenberg RA, Wilson HA III, Koffler D: Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction. Am J Med 1983, 74:837-844.
19. Hirohata S, Hirose S, Miyamoto T: Cerebrospinal fluid IgM, IgA, and IgG indexes in systemic lupus erythematosus. Their use as estimates of central nervous system disease activity. Arch Intern Med 1985, 145:1843-1846.
20. Hirohata S, Arinuma Y, Yanagida T, Yoshio T: Blood-brain barrier damages and intrathecal synthesis of anti-N-methyl-D-aspartate receptor NR2 antibodies in diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus. Arthritis Res Ther 2014, 16:R77.
21. Furukawa H, Gouaux E: Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand-binding core. EMBO J 2003, 22:2873-2885.
22. Lauvsnes MB, Omdal R: Systemic lupus erythematosus, the brain, and anti-NR2 antibodies. J Neurol 2012, 259:622-629.
23. Yoshio T, Masuyama J, Kano S: Antiribosomal P0 protein antibodies react with the surface of human umbilical vein endothelial cells. J Rheumatol 1996, 23:1311-1312.
24. Nagai T, Arinuma Y, Yanagida T, Yamamoto K, Hirohata S: Anti-ribosomal P protein antibody in human systemic lupus erythematosus up-regulates the expression of proinflammatory cytokines by human peripheral blood monocytes. Arthritis Rheum 2005, 52:847-855.
25. Yoshio T, Okamoto H, Hirohata S, Minota S: IgG anti-NR2 glutamate receptor autoantibodies from patients with systemic lupus erythematosus activate endothelial cells. Arthritis Rheum 2013, 65:457-463.
26. Bhatnagar H, Kala S, Sharma L, Jain S, Kim KS, Pal R: Serum and organassociated anti-hemoglobin humoral autoreactivity: association with anti-Sm responses and inflammation. Eur J Immunol 2011, 41:537-548.
27. Hirohata S, Arinuma Y, Takayama M, Yoshio T: Association of cerebrospinal fluid anti-ribosomal P protein antibodies with diffuse psychiatric/ neuropsychological syndromes in systemic lupus erythematosus. Arthritis Res Ther 2007, 9:R44.
28. Fancellu R, Pareyson D, Corsini E, Salsano E, Laurà M, Bernardi G, Antozzi C, Andreetta F, Colecchia M, Di Donato S, Mariotti C: Immunological reactivity against neuronal and non-neuronal antigens in sporadic adult-onset cerebellar ataxia. Eur Neurol 2009, 62:356-361.
29. Caronti B, Pittoni V, Palladini G, Valesini G: Anti-beta 2-glycoprotein I antibodies bind to central nervous system. J Neurol Sci 1998, 156:211-219.